MyAverix Finance
F · Healthcare
Enlivex Therapeutics Ltd (1BT)
Biotechnology
Enlivex Therapeutics Ltd (1BT) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1BT
Enlivex Therapeutics Ltd (1BT) — FAQ
What is 1BT's P/E ratio?
The price-to-earnings (P/E) ratio for Enlivex Therapeutics Ltd (1BT) is 25.00 (data as of 2026-05-24).
Does Enlivex Therapeutics Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Enlivex Therapeutics Ltd (1BT). Check the MyAverix Finance app for the latest dividend data.
What sector is Enlivex Therapeutics Ltd in?
Enlivex Therapeutics Ltd (1BT) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1BT listed on?
1BT is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.